| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |